NCT02806102View on ClinicalTrials.gov

CardiOvascular Risk and idEntificAtion of Potential High-risk Population in Acute Myocardial Infarction II (COREA-AMI II)

UnknownOBSERVATIONAL
Enrollment

13,000

Participants

Timeline

Start Date

January 31, 2004

Primary Completion Date

February 28, 2017

Study Completion Date

February 28, 2018

Conditions
Acute Myocardial InfarctionPercutaneous Coronary InterventionMajor Adverse Cardiovascular EventsBleeding
Interventions
PROCEDURE

Percutaneous coronary intervention

Percutaneous coronary intervention

DRUG

Dual-antiplatelet therapy

Dual AntiPlatelet Therapy

PROCEDURE

Percutaneous coronary intervention

Percutaneous coronary intervention

DRUG

Dual-antiplatelet therapy

Dual AntiPlatelet Therapy

Trial Locations (2)

Unknown

RECRUITING

Chonnam National University Hospital, Gwangju

RECRUITING

Seoul St. Mary's Hospital, The Catholic University of Korea, Seoul

Sponsors

Collaborators (1)

AstraZeneca
All Listed Sponsors
collaborator

The Catholic University of Korea

OTHER

collaborator

Chonnam National University

OTHER

collaborator

AstraZeneca

INDUSTRY

lead

Seoul St. Mary's Hospital

OTHER